Position in INM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$379,788
New position
Shares Held
245,025
first reported quarter
Ownership
4.46%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4
of 20 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $50,945,474 across 10 Drug Manufacturers - Specialty & Generic names. INM ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
272,085 | $22,523,196 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
188,381 | $6,531,169 | |
| 3 | HROW |
Harrow, Inc.
|
135,775 | $5,766,364 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
200,000 | $4,902,000 | |
| 5 | CRDL |
Cardiol Therapeutics Inc.
|
3,325,000 | $3,524,500 | |
| 6 | CPIX |
Cumberland Pharmaceuticals Inc
|
503,153 | $3,260,431 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
117,500 | $2,110,300 | |
| 8 | DERM |
Journey Medical Corp
|
251,436 | $1,780,166 |
All Filings in INM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,788 | 245,025 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||